Clinical Trial Update: Rituximab/Bendamustine + Rituximab/Cytarabine for Mantle Cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial in Mantle Cell Lymphoma evaluating two Rituximab-based regimens (Rituximab/Bendamustine and Rituximab/Cytarabine); results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Rituxan (rituximab)
• Treanda (Bendamustine)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Mantle Cell Lymphoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2017-01-12